🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bio-Techne Corporation

TECH Healthcare
$72.48 +$0.26 (0.36%)
Market Cap: $11.29 B
Gurus Holding
14
Popularity Rank
#112
% of Shares Held
6.87%
Net Activity (Q2 2026)
-$147.65 M

Guru Ownership Trend

Guru Analysis for Bio-Techne Corporation (TECH)

Bio-Techne Corporation (TECH), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 14 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $776.24 M.

Top institutional holders include Ruane Cunniff and Mairs and Power.

Institutional sentiment is currently Bearish. This is evidenced by a $147.65 M net outflow during the quarter.

Recent activity highlights Ray Dalio who increased their stake by 347.6%. Conversely, Larry Robbins reduced exposure by 68.7%.

Key Holders

Top 5 by Value

$236.6 M
$190.8 M
$108.49 M
$66.64 M
$55.8 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$120.54 M
Total Buy Value
New Buys 5
Additions 3
-$268.19 M
Total Sell Value
Reductions 6
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
7
Net Buyers
8

FAQs for Bio-Techne Corporation (TECH)

Major holders include Ruane Cunniff ($236.6 M), Mairs and Power ($190.8 M), Lee Ainslie ($108.49 M). According to the latest reported data, 14 tracked investment managers collectively hold approximately 10.71 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $147.65 M, with 8 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited TECH. The total reported sell value was $268.19 M.

Yes, 5 managers opened new positions in TECH, and 3 increased their existing holdings. The total reported buy value was $120.54 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.68% Reduce -1.3% 3,348,841 $236.6 M Q2 2026
1.75% Reduce -1.8% 2,700,698 $190.8 M Q2 2026
0.96% Reduce -67.6% 1,535,610 $108.49 M Q2 2026
0.09% New Buy 943,287 $66.64 M Q2 2026
0.45% Add 4.0% 789,745 $55.8 M Q2 2026
2.66% Reduce -16.8% 543,200 $38.38 M Q2 2026
0.46% New Buy 535,400 $37.83 M Q2 2026
0.13% New Buy 125,626 $8.88 M Q2 2026
0.01% Add 169.4% 71,175 $5.03 M Q2 2026
0.08% Reduce -68.7% 58,324 $4.12 M Q2 2026
0.01% Add 347.6% 26,750 $1.89 M Q2 2026
0.00% Reduce -63.5% 24,785 $1.75 M Q2 2026
0.00% New Buy 6,250 $441,563 Q2 2026
0.00% New Buy 52 $3,687 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form